Skip to main content
PMC home page
Biochemical Journal logoLink to Biochemical Journal
. 2000 May 15;348(Pt 1):55–61.

Identification and expression analysis of leptin-regulated immediate early response and late target genes.

W Waelput 1, A Verhee 1, D Broekaert 1, S Eyckerman 1, J Vandekerckhove 1, J H Beattie 1, J Tavernier 1
PMCID: PMC1221035  PMID: 10794713

Abstract

Using PC12 cells as an in vitro model system, we have identified a series of transcripts induced through activation of the leptin receptor. On the basis of kinetic studies, two distinct gene sets could be discerned: signal transducer and activator of transciption-3 (STAT-3), suppressor of cytokine signalling-3 (SOCS-3), MT-II (metallothionein-II), the serine/threonine kinase fibroblast-growth-factor-inducible kinase (Fnk) and modulator recognition factor (MRF-1), which are immediate early response genes, and pancreatitis-associated protein I (PAP I), squalene epoxidase, uridine diphosphate glucuronosyltransferase and annexin VIII, which are late induced target genes. At late time points a strong co-stimulation with beta-nerve growth factor or with the adenylate cyclase activator forskolin was observed. To assess the validity of the PC12-cell model system, we examined the effect of leptin administration on the gene transcription of STAT-3, MT-II, Fnk and PAP I in vivo. Leptin treatment of leptin-deficient ob/ob mice increased the STAT-3, SOCS-3, MT-II and Fnk mRNA, and MT-I protein levels in liver, whereas, in jejunum, expression of PAP I mRNA was down-regulated. Furthermore, administration of leptin to starved wild-type mice enhanced the expression of MT-II and Fnk mRNA in liver, but decreased MT-II and PAP I mRNA expression in jejunum. These findings may help to explain the obese phenotype observed in some colonies of MT-I- and MT-II-null mice and/or the observation that leptin protects against tumour-necrosis-factor toxicity in vivo.

Full Text

The Full Text of this article is available as a PDF (221.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abdel-Mageed A. B., Agrawal K. C. Activation of nuclear factor kappaB: potential role in metallothionein-mediated mitogenic response. Cancer Res. 1998 Jun 1;58(11):2335–2338. [PubMed] [Google Scholar]
  2. Adams T. E., Hansen J. A., Starr R., Nicola N. A., Hilton D. J., Billestrup N. Growth hormone preferentially induces the rapid, transient expression of SOCS-3, a novel inhibitor of cytokine receptor signaling. J Biol Chem. 1998 Jan 16;273(3):1285–1287. doi: 10.1074/jbc.273.3.1285. [DOI] [PubMed] [Google Scholar]
  3. Ahima R. S., Prabakaran D., Mantzoros C., Qu D., Lowell B., Maratos-Flier E., Flier J. S. Role of leptin in the neuroendocrine response to fasting. Nature. 1996 Jul 18;382(6588):250–252. doi: 10.1038/382250a0. [DOI] [PubMed] [Google Scholar]
  4. Augustine K. A., Rossi R. M. Rodent mutant models of obesity and their correlations to human obesity. Anat Rec. 1999 Apr 15;257(2):64–72. doi: 10.1002/(SICI)1097-0185(19990415)257:2<64::AID-AR7>3.0.CO;2-G. [DOI] [PubMed] [Google Scholar]
  5. Baumann H., Morella K. K., White D. W., Dembski M., Bailon P. S., Kim H., Lai C. F., Tartaglia L. A. The full-length leptin receptor has signaling capabilities of interleukin 6-type cytokine receptors. Proc Natl Acad Sci U S A. 1996 Aug 6;93(16):8374–8378. doi: 10.1073/pnas.93.16.8374. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Beattie J. H., Wood A. M., Newman A. M., Bremner I., Choo K. H., Michalska A. E., Duncan J. S., Trayhurn P. Obesity and hyperleptinemia in metallothionein (-I and -II) null mice. Proc Natl Acad Sci U S A. 1998 Jan 6;95(1):358–363. doi: 10.1073/pnas.95.1.358. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Bjørbaek C., Elmquist J. K., Frantz J. D., Shoelson S. E., Flier J. S. Identification of SOCS-3 as a potential mediator of central leptin resistance. Mol Cell. 1998 Mar;1(4):619–625. doi: 10.1016/s1097-2765(00)80062-3. [DOI] [PubMed] [Google Scholar]
  8. Braun B. S., Frieden R., Lessnick S. L., May W. A., Denny C. T. Identification of target genes for the Ewing's sarcoma EWS/FLI fusion protein by representational difference analysis. Mol Cell Biol. 1995 Aug;15(8):4623–4630. doi: 10.1128/mcb.15.8.4623. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Campfield L. A., Smith F. J., Burn P. Strategies and potential molecular targets for obesity treatment. Science. 1998 May 29;280(5368):1383–1387. doi: 10.1126/science.280.5368.1383. [DOI] [PubMed] [Google Scholar]
  10. Campfield L. A., Smith F. J., Guisez Y., Devos R., Burn P. Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science. 1995 Jul 28;269(5223):546–549. doi: 10.1126/science.7624778. [DOI] [PubMed] [Google Scholar]
  11. Chen H., Charlat O., Tartaglia L. A., Woolf E. A., Weng X., Ellis S. J., Lakey N. D., Culpepper J., Moore K. J., Breitbart R. E. Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell. 1996 Feb 9;84(3):491–495. doi: 10.1016/s0092-8674(00)81294-5. [DOI] [PubMed] [Google Scholar]
  12. Cohen S. M., Werrmann J. G., Tota M. R. 13C NMR study of the effects of leptin treatment on kinetics of hepatic intermediary metabolism. Proc Natl Acad Sci U S A. 1998 Jun 23;95(13):7385–7390. doi: 10.1073/pnas.95.13.7385. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Considine R. V., Caro J. F. Leptin and the regulation of body weight. Int J Biochem Cell Biol. 1997 Nov;29(11):1255–1272. doi: 10.1016/s1357-2725(97)00050-2. [DOI] [PubMed] [Google Scholar]
  14. Considine R. V., Considine E. L., Williams C. J., Nyce M. R., Magosin S. A., Bauer T. L., Rosato E. L., Colberg J., Caro J. F. Evidence against either a premature stop codon or the absence of obese gene mRNA in human obesity. J Clin Invest. 1995 Jun;95(6):2986–2988. doi: 10.1172/JCI118007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Emilsson V., Arch J. R., de Groot R. P., Lister C. A., Cawthorne M. A. Leptin treatment increases suppressors of cytokine signaling in central and peripheral tissues. FEBS Lett. 1999 Jul 16;455(1-2):170–174. doi: 10.1016/s0014-5793(99)00874-1. [DOI] [PubMed] [Google Scholar]
  16. Eyckerman S., Waelput W., Verhee A., Broekaert D., Vandekerckhove J., Tavernier J. Analysis of Tyr to Phe and fa/fa leptin receptor mutations in the PC12 cell line. Eur Cytokine Netw. 1999 Dec;10(4):549–556. [PubMed] [Google Scholar]
  17. Fei H., Okano H. J., Li C., Lee G. H., Zhao C., Darnell R., Friedman J. M. Anatomic localization of alternatively spliced leptin receptors (Ob-R) in mouse brain and other tissues. Proc Natl Acad Sci U S A. 1997 Jun 24;94(13):7001–7005. doi: 10.1073/pnas.94.13.7001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Fischer E. H., Davie E. W. Recent excitement regarding metallothionein. Proc Natl Acad Sci U S A. 1998 Mar 31;95(7):3333–3334. doi: 10.1073/pnas.95.7.3333. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Flier J. S. Leptin expression and action: new experimental paradigms. Proc Natl Acad Sci U S A. 1997 Apr 29;94(9):4242–4245. doi: 10.1073/pnas.94.9.4242. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Friedman J. M., Halaas J. L. Leptin and the regulation of body weight in mammals. Nature. 1998 Oct 22;395(6704):763–770. doi: 10.1038/27376. [DOI] [PubMed] [Google Scholar]
  21. Gainsford T., Willson T. A., Metcalf D., Handman E., McFarlane C., Ng A., Nicola N. A., Alexander W. S., Hilton D. J. Leptin can induce proliferation, differentiation, and functional activation of hemopoietic cells. Proc Natl Acad Sci U S A. 1996 Dec 10;93(25):14564–14568. doi: 10.1073/pnas.93.25.14564. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Ghilardi N., Ziegler S., Wiestner A., Stoffel R., Heim M. H., Skoda R. C. Defective STAT signaling by the leptin receptor in diabetic mice. Proc Natl Acad Sci U S A. 1996 Jun 25;93(13):6231–6235. doi: 10.1073/pnas.93.13.6231. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Halaas J. L., Gajiwala K. S., Maffei M., Cohen S. L., Chait B. T., Rabinowitz D., Lallone R. L., Burley S. K., Friedman J. M. Weight-reducing effects of the plasma protein encoded by the obese gene. Science. 1995 Jul 28;269(5223):543–546. doi: 10.1126/science.7624777. [DOI] [PubMed] [Google Scholar]
  24. Hamilton B. S., Paglia D., Kwan A. Y., Deitel M. Increased obese mRNA expression in omental fat cells from massively obese humans. Nat Med. 1995 Sep;1(9):953–956. doi: 10.1038/nm0995-953. [DOI] [PubMed] [Google Scholar]
  25. Higuchi H., Yang H. Y., Sabol S. L. Rat neuropeptide Y precursor gene expression. mRNA structure, tissue distribution, and regulation by glucocorticoids, cyclic AMP, and phorbol ester. J Biol Chem. 1988 May 5;263(13):6288–6295. [PubMed] [Google Scholar]
  26. Hoggard N., Mercer J. G., Rayner D. V., Moar K., Trayhurn P., Williams L. M. Localization of leptin receptor mRNA splice variants in murine peripheral tissues by RT-PCR and in situ hybridization. Biochem Biophys Res Commun. 1997 Mar 17;232(2):383–387. doi: 10.1006/bbrc.1997.6245. [DOI] [PubMed] [Google Scholar]
  27. Hubank M., Schatz D. G. Identifying differences in mRNA expression by representational difference analysis of cDNA. Nucleic Acids Res. 1994 Dec 25;22(25):5640–5648. doi: 10.1093/nar/22.25.5640. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Kauselmann G., Weiler M., Wulff P., Jessberger S., Konietzko U., Scafidi J., Staubli U., Bereiter-Hahn J., Strebhardt K., Kuhl D. The polo-like protein kinases Fnk and Snk associate with a Ca(2+)- and integrin-binding protein and are regulated dynamically with synaptic plasticity. EMBO J. 1999 Oct 15;18(20):5528–5539. doi: 10.1093/emboj/18.20.5528. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Lazo J. S., Kondo Y., Dellapiazza D., Michalska A. E., Choo K. H., Pitt B. R. Enhanced sensitivity to oxidative stress in cultured embryonic cells from transgenic mice deficient in metallothionein I and II genes. J Biol Chem. 1995 Mar 10;270(10):5506–5510. doi: 10.1074/jbc.270.10.5506. [DOI] [PubMed] [Google Scholar]
  30. Lee D. K., Carrasco J., Hidalgo J., Andrews G. K. Identification of a signal transducer and activator of transcription (STAT) binding site in the mouse metallothionein-I promoter involved in interleukin-6-induced gene expression. Biochem J. 1999 Jan 1;337(Pt 1):59–65. [PMC free article] [PubMed] [Google Scholar]
  31. Lee G. H., Proenca R., Montez J. M., Carroll K. M., Darvishzadeh J. G., Lee J. I., Friedman J. M. Abnormal splicing of the leptin receptor in diabetic mice. Nature. 1996 Feb 15;379(6566):632–635. doi: 10.1038/379632a0. [DOI] [PubMed] [Google Scholar]
  32. Lord G. M., Matarese G., Howard J. K., Baker R. J., Bloom S. R., Lechler R. I. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature. 1998 Aug 27;394(6696):897–901. doi: 10.1038/29795. [DOI] [PubMed] [Google Scholar]
  33. Lönnqvist F., Arner P., Nordfors L., Schalling M. Overexpression of the obese (ob) gene in adipose tissue of human obese subjects. Nat Med. 1995 Sep;1(9):950–953. doi: 10.1038/nm0995-950. [DOI] [PubMed] [Google Scholar]
  34. Maffei M., Halaas J., Ravussin E., Pratley R. E., Lee G. H., Zhang Y., Fei H., Kim S., Lallone R., Ranganathan S. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med. 1995 Nov;1(11):1155–1161. doi: 10.1038/nm1195-1155. [DOI] [PubMed] [Google Scholar]
  35. Mehra R. K., Bremner I. Development of a radioimmunoassay for rat liver metallothionein-I and its application to the analysis of rat plasma and kidneys. Biochem J. 1983 Aug 1;213(2):459–465. doi: 10.1042/bj2130459. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Mercer J. G., Hoggard N., Williams L. M., Lawrence C. B., Hannah L. T., Trayhurn P. Localization of leptin receptor mRNA and the long form splice variant (Ob-Rb) in mouse hypothalamus and adjacent brain regions by in situ hybridization. FEBS Lett. 1996 Jun 3;387(2-3):113–116. doi: 10.1016/0014-5793(96)00473-5. [DOI] [PubMed] [Google Scholar]
  37. Morton N. M., Emilsson V., Liu Y. L., Cawthorne M. A. Leptin action in intestinal cells. J Biol Chem. 1998 Oct 2;273(40):26194–26201. doi: 10.1074/jbc.273.40.26194. [DOI] [PubMed] [Google Scholar]
  38. Nakamura Y., Sakakibara J., Izumi T., Shibata A., Ono T. Transcriptional regulation of squalene epoxidase by sterols and inhibitors in HeLa cells. J Biol Chem. 1996 Apr 5;271(14):8053–8056. doi: 10.1074/jbc.271.14.8053. [DOI] [PubMed] [Google Scholar]
  39. Pelleymounter M. A., Cullen M. J., Baker M. B., Hecht R., Winters D., Boone T., Collins F. Effects of the obese gene product on body weight regulation in ob/ob mice. Science. 1995 Jul 28;269(5223):540–543. doi: 10.1126/science.7624776. [DOI] [PubMed] [Google Scholar]
  40. Schroeder J. J., Cousins R. J. Interleukin 6 regulates metallothionein gene expression and zinc metabolism in hepatocyte monolayer cultures. Proc Natl Acad Sci U S A. 1990 Apr;87(8):3137–3141. doi: 10.1073/pnas.87.8.3137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Searle P. F., Davison B. L., Stuart G. W., Wilkie T. M., Norstedt G., Palmiter R. D. Regulation, linkage, and sequence of mouse metallothionein I and II genes. Mol Cell Biol. 1984 Jul;4(7):1221–1230. doi: 10.1128/mcb.4.7.1221. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Sierra-Honigmann M. R., Nath A. K., Murakami C., García-Cardeña G., Papapetropoulos A., Sessa W. C., Madge L. A., Schechner J. S., Schwabb M. B., Polverini P. J. Biological action of leptin as an angiogenic factor. Science. 1998 Sep 11;281(5383):1683–1686. doi: 10.1126/science.281.5383.1683. [DOI] [PubMed] [Google Scholar]
  43. Stephens T. W., Basinski M., Bristow P. K., Bue-Valleskey J. M., Burgett S. G., Craft L., Hale J., Hoffmann J., Hsiung H. M., Kriauciunas A. The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature. 1995 Oct 12;377(6549):530–532. doi: 10.1038/377530a0. [DOI] [PubMed] [Google Scholar]
  44. Takahashi N., Waelput W., Guisez Y. Leptin is an endogenous protective protein against the toxicity exerted by tumor necrosis factor. J Exp Med. 1999 Jan 4;189(1):207–212. [PMC free article] [PubMed] [Google Scholar]
  45. Tartaglia L. A., Dembski M., Weng X., Deng N., Culpepper J., Devos R., Richards G. J., Campfield L. A., Clark F. T., Deeds J. Identification and expression cloning of a leptin receptor, OB-R. Cell. 1995 Dec 29;83(7):1263–1271. doi: 10.1016/0092-8674(95)90151-5. [DOI] [PubMed] [Google Scholar]
  46. Unger R. H., Zhou Y. T., Orci L. Regulation of fatty acid homeostasis in cells: novel role of leptin. Proc Natl Acad Sci U S A. 1999 Mar 2;96(5):2327–2332. doi: 10.1073/pnas.96.5.2327. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Vaisse C., Halaas J. L., Horvath C. M., Darnell J. E., Jr, Stoffel M., Friedman J. M. Leptin activation of Stat3 in the hypothalamus of wild-type and ob/ob mice but not db/db mice. Nat Genet. 1996 Sep;14(1):95–97. doi: 10.1038/ng0996-95. [DOI] [PubMed] [Google Scholar]
  48. Verploegen S. A., Plaetinck G., Devos R., Van der Heyden J., Guisez Y. A human leptin mutant induces weight gain in normal mice. FEBS Lett. 1997 Mar 24;405(2):237–240. doi: 10.1016/s0014-5793(97)00192-0. [DOI] [PubMed] [Google Scholar]
  49. Zakrzewska K. E., Cusin I., Sainsbury A., Rohner-Jeanrenaud F., Jeanrenaud B. Glucocorticoids as counterregulatory hormones of leptin: toward an understanding of leptin resistance. Diabetes. 1997 Apr;46(4):717–719. doi: 10.2337/diab.46.4.717. [DOI] [PubMed] [Google Scholar]
  50. Zhang Y., Proenca R., Maffei M., Barone M., Leopold L., Friedman J. M. Positional cloning of the mouse obese gene and its human homologue. Nature. 1994 Dec 1;372(6505):425–432. doi: 10.1038/372425a0. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES